Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Bioharvest Sciences (BHST) over the last 3 years, with Q3 2025 value amounting to $59000.0.

  • Bioharvest Sciences' Change in Accured Expenses fell 9465.1% to $59000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year decrease of 491.8%. This contributed to the annual value of $1.0 million for FY2024, which is 3117.14% down from last year.
  • As of Q3 2025, Bioharvest Sciences' Change in Accured Expenses stood at $59000.0, which was down 9465.1% from $839000.0 recorded in Q2 2025.
  • Bioharvest Sciences' 5-year Change in Accured Expenses high stood at $1.1 million for Q3 2024, and its period low was -$301000.0 during Q4 2024.
  • Its 3-year average for Change in Accured Expenses is $355888.9, with a median of $372000.0 in 2024.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first crashed by 14876.03% in 2024, then skyrocketed by 52014.93% in 2025.
  • Quarter analysis of 3 years shows Bioharvest Sciences' Change in Accured Expenses stood at -$121000.0 in 2023, then crashed by 148.76% to -$301000.0 in 2024, then skyrocketed by 119.6% to $59000.0 in 2025.
  • Its last three reported values are $59000.0 in Q3 2025, $839000.0 for Q2 2025, and $563000.0 during Q1 2025.